Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Rating) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 108,200 shares, a growth of 27.6% from the March 31st total of 84,800 shares. Currently, 1.9% of the shares of the company are short […]
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Rating)’s stock price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $2.45 and traded as high as $3.95. Soleno Therapeutics shares last traded at $3.70, with a volume of 31,804 shares changing hands. Analyst Ratings Changes Separately, Oppenheimer […]
Oppenheimer reissued their outperform rating on shares of Soleno Therapeutics (NASDAQ:SLNO – Get Rating) in a report published on Friday, Benzinga reports. Oppenheimer currently has a $8.00 target price on the stock. Oppenheimer also issued estimates for Soleno Therapeutics’ FY2027 earnings at $4.09 EPS. Soleno Therapeutics Stock Performance Shares of Soleno Therapeutics stock opened at […]